STRATA Skin Sciences Inc
Buy, Hold or Sell?
Let's analyse STRATA Skin Sciences Inc together
I guess you are interested in STRATA Skin Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.
I'm going to help you getting a better view of STRATA Skin Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.
You can find me behind Let's Analyse Together in the top-right of each section.
Get notifications about STRATA Skin Sciences Inc
I send you an email if I find something interesting about STRATA Skin Sciences Inc.
Quick analysis of STRATA Skin Sciences Inc (30 sec.)
What can you expect buying and holding a share of STRATA Skin Sciences Inc? (30 sec.)
How much money do you get?
How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%
What is your share worth?
Current worth
$0.36
Expected worth in 1 year
$-0.68
How sure are you?
40.0%
+ What do you gain per year?
Total Gains per Share
$-1.04
Return On Investment
-202.8%
1. Valuation of STRATA Skin Sciences Inc (5 min.)
Live pricePrice per Share (EOD)
$0.51
$0.36
Intrinsic Value Per Share
$-2.79 - $1.89
Total Value Per Share
$-2.43 - $2.25
2. Growth of STRATA Skin Sciences Inc (5 min.)
Is STRATA Skin Sciences Inc growing?
| Current year | Previous year | Grow | Grow % | |
|---|---|---|---|---|
| How rich? | $12.6m | $21.8m | -$9.1m | -72.1% |
How much money is STRATA Skin Sciences Inc making?
| Current year | Previous year | Grow | Grow % | |
|---|---|---|---|---|
| Making money | -$10.8m | -$5.5m | -$5.2m | -48.8% |
| Net Profit Margin | -32.5% | -15.3% | - | - |
How much money comes from the company's main activities?
3. Financial Health of STRATA Skin Sciences Inc (5 min.)
4. Comparing to competitors in the Medical Devices industry (5 min.)
Industry Rankings (Medical Devices)
What can you expect buying and holding a share of STRATA Skin Sciences Inc? (5 min.)
Welcome investor! STRATA Skin Sciences Inc's management wants to use your money to grow the business. In return you get a share of STRATA Skin Sciences Inc.
What can you expect buying and holding a share of STRATA Skin Sciences Inc?
First you should know what it really means to hold a share of STRATA Skin Sciences Inc. And how you can make/lose money.
Speculation
The Price per Share of STRATA Skin Sciences Inc is $0.5145. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.
If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:
- The fundamentals: the financial health trends of STRATA Skin Sciences Inc.
- The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
- The book value: what is the market price compared to it's book value.
Investing
If you really want to invest in STRATA Skin Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:
- You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.36. Based on the TTM, the Book Value Change Per Share is $-0.26 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.10 per quarter.
- You may receive quarterly/yearly dividend in the form of additional shares.
- You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
How much money are you going to get?
| MRQ | TTM | YOY | 5Y | 10Y | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| $ | % of Price per Share | $ | % of Price per Share | $ | % of Price per Share | $ | % of Price per Share | $ | % of Price per Share | |
| Usd Eps | -0.31 | -60.1% | -0.31 | -60.1% | -0.16 | -30.8% | -0.15 | -30.1% | -0.27 | -53.3% |
| Usd Book Value Change Per Share | -0.26 | -50.7% | -0.26 | -50.7% | -0.10 | -19.9% | -0.11 | -20.6% | 0.01 | 2.4% |
| Usd Dividend Per Share | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% |
| Usd Total Gains Per Share | -0.26 | -50.7% | -0.26 | -50.7% | -0.10 | -19.9% | -0.11 | -20.6% | 0.01 | 2.4% |
| Usd Price Per Share | 0.55 | - | 0.55 | - | 0.79 | - | 1.28 | - | 1.30 | - |
| Price to Earnings Ratio | -1.78 | - | -1.78 | - | -4.99 | - | -11.59 | - | -10.02 | - |
| Price-to-Total Gains Ratio | -2.11 | - | -2.11 | - | -7.73 | - | -31.77 | - | -11.30 | - |
| Price to Book Ratio | 1.52 | - | 1.52 | - | 1.27 | - | 1.83 | - | 2.09 | - |
| Price-to-Total Gains Ratio | -2.11 | - | -2.11 | - | -7.73 | - | -31.77 | - | -11.30 | - |
When do you get the money?
| Usd Investment | |
|---|---|
| Usd Price Per Share | 0.5145 |
| Number of shares | 1943 |
| Gains per Quarter | Trailing 12 Months | 5 Year |
|---|---|---|
| Usd Dividend Per Share | 0.00 | 0.00 |
| Usd Book Value Change Per Share | -0.26 | -0.11 |
| Usd Total Gains Per Share | -0.26 | -0.11 |
| Gains per Quarter (1943 shares) | -506.86 | -205.78 |
| Gains per Year (1943 shares) | -2,027.44 | -823.13 |
| Years | Return on Investment (TTM) | Return on Investment (5Y) | ||||
|---|---|---|---|---|---|---|
| Dividend | Book Value gain | Total gains | Dividend | Book Value gain | Total gains | |
| Broker costs | - | - | -10 | - | - | -10 |
| 1 | 0 | -2027 | -2037 | 0 | -823 | -833 |
| 2 | 0 | -4055 | -4064 | 0 | -1646 | -1656 |
| 3 | 0 | -6082 | -6091 | 0 | -2469 | -2479 |
| 4 | 0 | -8110 | -8118 | 0 | -3293 | -3302 |
| 5 | 0 | -10137 | -10145 | 0 | -4116 | -4125 |
| 6 | 0 | -12165 | -12172 | 0 | -4939 | -4948 |
| 7 | 0 | -14192 | -14199 | 0 | -5762 | -5771 |
| 8 | 0 | -16220 | -16226 | 0 | -6585 | -6594 |
| 9 | 0 | -18247 | -18253 | 0 | -7408 | -7417 |
| 10 | 0 | -20274 | -20280 | 0 | -8231 | -8240 |
How sure are you?
Based on the past periods, how sure are you to get value out of your investment.
Linear %
| Trailing 12 Months | 3Y | 5 Year | 10 Year | ALLTIME | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | % | % | % | % | ||||||||||||||||
| Earnings Per Share | 0.0 | 1.0 | 0.0 | 0.0% | 0.0 | 3.0 | 0.0 | 0.0% | 0.0 | 5.0 | 0.0 | 0.0% | 0.0 | 10.0 | 0.0 | 0.0% | 0.0 | 21.0 | 0.0 | 0.0% |
| Book Value Change Per Share | 0.0 | 1.0 | 0.0 | 0.0% | 0.0 | 3.0 | 0.0 | 0.0% | 0.0 | 4.0 | 1.0 | 0.0% | 4.0 | 5.0 | 1.0 | 40.0% | 8.0 | 12.0 | 1.0 | 38.1% |
| Dividend per Share | 0.0 | 0.0 | 1.0 | 0.0% | 0.0 | 0.0 | 3.0 | 0.0% | 0.0 | 0.0 | 5.0 | 0.0% | 0.0 | 0.0 | 10.0 | 0.0% | 0.0 | 0.0 | 21.0 | 0.0% |
| Total Gains per Share | 0.0 | 1.0 | 0.0 | 0.0% | 0.0 | 3.0 | 0.0 | 0.0% | 0.0 | 4.0 | 1.0 | 0.0% | 4.0 | 5.0 | 1.0 | 40.0% | 8.0 | 12.0 | 1.0 | 38.1% |
Fundamentals of STRATA Skin Sciences Inc
About STRATA Skin Sciences Inc
- https://www.strataskinsciences.com
- Medical Devices
- 114
- 5 Walnut Grove Drive, Horsham, PA, United States, 19044
Google Maps Bing Maps
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also provides TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Fundamental data was last updated by Penke on 2024-04-12 19:05:06.
Financial Health
Profitability Details
| Compared to previous year | Compared to industry | |
|---|---|---|
| The company is making a huge loss. | ||
| Using its assets, the company is very inefficient in making profit. | ||
| Using its investors money, the company is very inefficient in making profit. |
Operating Efficiency Details
| Compared to previous year | Compared to industry | |
|---|---|---|
| The company is operating very inefficient. | ||
| The company is inefficient in keeping operating costs low. |
Liquidity Details
| Compared to previous year | Compared to industry | |
|---|---|---|
| The company is just able to pay all its short-term debts. | ||
| The company is just able to pay all its short-term debts with the most liquid assets. |
Solvency Details
| Compared to previous year | Compared to industry | |
|---|---|---|
| The company is able to pay all its debts by selling its assets. | ||
| The company is just not able to pay all its debts with equity. |
Valuation
Valuation Details
| Compared to previous year | Compared to industry | |
|---|---|---|
| Based on the equity, the company is underpriced. | ||
| Based on the earnings, the company is expensive. | ||
| Based on how much money comes from the company's main activities, the company is expensive. |
1.1. Profitability of STRATA Skin Sciences Inc.
1.1. Profitability
1.1.1. Net Profit Margin
Measures how much net profit STRATA Skin Sciences Inc earns for each $1 of revenue.
- Above 10% is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
- A Net Profit Margin of -32.5% means that $-0.32 for each $1 in revenue is generated as profit.
Let's take a look of the Net Profit Margin trends of STRATA Skin Sciences Inc:
Trends
- The YOY is -15.3%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -17.9%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is -208.5%. Compared to the 5Y term, the 10Y term is trending up. +2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| MRQ | -32.5% | TTM | -32.5% | 0.0% | |
| TTM | -32.5% | YOY | -15.3% | -17.1% | |
| TTM | -32.5% | 5Y | -17.9% | -14.6% | |
| 5Y | -17.9% | 10Y | -208.5% | +190.6% | |
Compared to industry (Medical Devices)
Let compare the company's Net Profit Margin with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -12.4%. trending down. -2
- The TTM average (mean) in the Medical Devices industry is -20.4%. trending down. -2
1.1.2. Return on Assets
Shows how efficient STRATA Skin Sciences Inc is using its assets to generate profit.
- Above 5% is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
- -25.8% Return on Assets means that STRATA Skin Sciences Inc generated $-0.26 profit for each $1 in assets.
Let's take a look of the Return on Assets trends of STRATA Skin Sciences Inc:
Trends
- The YOY is -10.6%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -12.0%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is -26.6%. Compared to the 5Y term, the 10Y term is trending up. +2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| MRQ | -25.8% | TTM | -25.8% | 0.0% | |
| TTM | -25.8% | YOY | -10.6% | -15.2% | |
| TTM | -25.8% | 5Y | -12.0% | -13.8% | |
| 5Y | -12.0% | 10Y | -26.6% | +14.6% | |
Compared to industry (Medical Devices)
Let compare the company's Return on Assets with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -4.1%. trending down. -2
- The TTM average (mean) in the Medical Devices industry is -4.7%. trending down. -2
1.1.3. Return on Equity
Shows how efficient STRATA Skin Sciences Inc is using its investors money to generate profit.
- Above 15%-20% is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
- -85.4% Return on Equity means STRATA Skin Sciences Inc generated $-0.85 for each $1 the owners (shareholders) invested.
Let's take a look of the Return on Equity trends of STRATA Skin Sciences Inc:
Trends
- The YOY is -25.4%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -30.3%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is -58.8%. Compared to the 5Y term, the 10Y term is trending up. +2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| MRQ | -85.4% | TTM | -85.4% | 0.0% | |
| TTM | -85.4% | YOY | -25.4% | -59.9% | |
| TTM | -85.4% | 5Y | -30.3% | -55.1% | |
| 5Y | -30.3% | 10Y | -58.8% | +28.5% | |
Compared to industry (Medical Devices)
Let compare the company's Return on Equity with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -4.2%. trending down. -2
- The TTM average (mean) in the Medical Devices industry is -5.8%. trending down. -2
1.2. Operating Efficiency of STRATA Skin Sciences Inc.
1.2. Operating Efficiency
1.2.1. Operating Margin
Measures how efficient STRATA Skin Sciences Inc is operating .
- Measures how much profit STRATA Skin Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
- Above 15% is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
- An Operating Margin of -18.9% means the company generated $-0.19 for each $1 in revenue (before taxes).
Let's take a look of the Operating Margin trends of STRATA Skin Sciences Inc:
Trends
- The YOY is -12.6%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -15.7%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is -157.9%. Compared to the 5Y term, the 10Y term is trending up. +2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| MRQ | -18.9% | TTM | -18.9% | 0.0% | |
| TTM | -18.9% | YOY | -12.6% | -6.3% | |
| TTM | -18.9% | 5Y | -15.7% | -3.3% | |
| 5Y | -15.7% | 10Y | -157.9% | +142.2% | |
Compared to industry (Medical Devices)
Let compare the company's Operating Margin with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -24.3%. trending up. +2
- The TTM average (mean) in the Medical Devices industry is -16.4%. trending down. -2
1.2.2. Operating Ratio
Measures how efficient STRATA Skin Sciences Inc is keeping operating costs low.
- Below 1 is considered healthy (always compare to Medical Devices industry mean).
- An Operation Ratio of 1.19 means that the operating costs are $1.19 for each $1 in net sales.
Let's take a look of the Operating Ratio trends of STRATA Skin Sciences Inc:
Trends
- The YOY is 1.129. Compared to the TTM, the mid term is trending up. -2
- The 5Y is 1.151. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is 3.011. Compared to the 5Y term, the 10Y term is trending down. +2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| MRQ | 1.189 | TTM | 1.189 | 0.000 | |
| TTM | 1.189 | YOY | 1.129 | +0.061 | |
| TTM | 1.189 | 5Y | 1.151 | +0.039 | |
| 5Y | 1.151 | 10Y | 3.011 | -1.861 | |
Compared to industry (Medical Devices)
Let compare the company's Operating Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 1.456. trending down. +2
- The TTM average (mean) in the Medical Devices industry is 1.439. trending down. +2
1.3. Liquidity of STRATA Skin Sciences Inc.
1.3. Liquidity
1.3.1. Current Ratio
Measures if STRATA Skin Sciences Inc is able to pay off Short-term Debt.
- Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
- A Current Ratio of 1.28 means the company has $1.28 in assets for each $1 in short-term debts.
Let's take a look of the Current Ratio trends of STRATA Skin Sciences Inc:
Trends
- The YOY is 1.304. Compared to the TTM, the mid term is trending down. -2
- The 5Y is 1.631. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 2.217. Compared to the 5Y term, the 10Y term is trending down. -2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| MRQ | 1.277 | TTM | 1.277 | 0.000 | |
| TTM | 1.277 | YOY | 1.304 | -0.027 | |
| TTM | 1.277 | 5Y | 1.631 | -0.354 | |
| 5Y | 1.631 | 10Y | 2.217 | -0.587 | |
Compared to industry (Medical Devices)
Let compare the company's Current Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 2.693. trending down. -2
- The TTM average (mean) in the Medical Devices industry is 2.697. trending down. -2
1.3.2. Quick Ratio
Measures if STRATA Skin Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.
- Above 1 is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
- A Quick Ratio of 1.03 means the company can pay off $1.03 for each $1 in debt (using most liquid assets).
Let's take a look of the Quick Ratio trends of STRATA Skin Sciences Inc:
Trends
- The YOY is 0.738. Compared to the TTM, the mid term is trending up. +2
- The 5Y is 1.209. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 1.592. Compared to the 5Y term, the 10Y term is trending down. -2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| MRQ | 1.032 | TTM | 1.032 | 0.000 | |
| TTM | 1.032 | YOY | 0.738 | +0.294 | |
| TTM | 1.032 | 5Y | 1.209 | -0.178 | |
| 5Y | 1.209 | 10Y | 1.592 | -0.382 | |
Compared to industry (Medical Devices)
Let compare the company's Quick Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 1.516. trending down. -2
- The TTM average (mean) in the Medical Devices industry is 1.658. trending down. -2
1.4. Solvency of STRATA Skin Sciences Inc.
1.3. Liquidity
1.4.1. Debt to Asset Ratio
Measures how much % of STRATA Skin Sciences Inc assets are financed with debt.
- Below 1 (100%) is considered healthy but always compare STRATA Skin Sciences Inc to Medical Devices industry mean.
- A Debt to Asset Ratio of 0.70 means that STRATA Skin Sciences Inc assets are financed with 69.8% credit (debt) and the remaining percentage (100% - 69.8%) is financed by its owners/shareholders.
Let's take a look of the Debt to Asset Ratio trends of STRATA Skin Sciences Inc:
Trends
- The YOY is 0.582. Compared to the TTM, the mid term is trending up. -2
- The 5Y is 0.505. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is 0.502. Compared to the 5Y term, the 10Y term is trending up. -2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| MRQ | 0.698 | TTM | 0.698 | 0.000 | |
| TTM | 0.698 | YOY | 0.582 | +0.116 | |
| TTM | 0.698 | 5Y | 0.505 | +0.193 | |
| 5Y | 0.505 | 10Y | 0.502 | +0.002 | |
Compared to industry (Medical Devices)
Let compare the company's Debt to Asset Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 0.402. trending up. -2
- The TTM average (mean) in the Medical Devices industry is 0.389. trending up. -2
1.4.2. Debt to Equity Ratio
Measures if STRATA Skin Sciences Inc is able to pay off its debts by using shareholders equity.
- Below 2 is considered healthy but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
- A Debt to Equity ratio of 231.1% means that company has $2.31 debt for each $1 in shareholders equity.
Let's take a look of the Debt to Equity Ratio trends of STRATA Skin Sciences Inc:
Trends
- The YOY is 1.394. Compared to the TTM, the mid term is trending up. -2
- The 5Y is 1.173. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is 1.189. Compared to the 5Y term, the 10Y term is trending down. +2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| MRQ | 2.311 | TTM | 2.311 | 0.000 | |
| TTM | 2.311 | YOY | 1.394 | +0.917 | |
| TTM | 2.311 | 5Y | 1.173 | +1.138 | |
| 5Y | 1.173 | 10Y | 1.189 | -0.015 | |
Compared to industry (Medical Devices)
Let compare the company's Debt to Equity Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 0.559. trending up. -2
- The TTM average (mean) in the Medical Devices industry is 0.560. trending up. -2
2. Market Valuation of STRATA Skin Sciences Inc
2.1. Earnings Per Share
2.1. Price to Earnings Ratio
Measures how much money you pay for each share for every $1 in earnings STRATA Skin Sciences Inc generates.
- Above 15 is considered overpriced but always compare STRATA Skin Sciences Inc to the Medical Devices industry mean.
- A PE ratio of -1.78 means the investor is paying $-1.78 for every $1 in earnings.
Let's take a look of the Price to Earnings Ratio trends of STRATA Skin Sciences Inc:
Trends
- The YOY is -4.990. Compared to the TTM, the mid term is trending up. -2
- The 5Y is -11.586. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is -10.019. Compared to the 5Y term, the 10Y term is trending down. +2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| EOD | -1.665 | MRQ | -1.780 | +0.115 | |
| MRQ | -1.780 | TTM | -1.780 | 0.000 | |
| TTM | -1.780 | YOY | -4.990 | +3.210 | |
| TTM | -1.780 | 5Y | -11.586 | +9.806 | |
| 5Y | -11.586 | 10Y | -10.019 | -1.567 | |
Compared to industry (Medical Devices)
Let compare the company's Price to Earnings Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -1.704. trending down. +2
- The TTM average (mean) in the Medical Devices industry is -2.081. trending up. -2
2.2. Price To Free Cash Flow Ratio
Let's take a look of the Price To Free Cash Flow Ratio trends of STRATA Skin Sciences Inc:
- The EOD is -3.256. Based on how much money comes from the company's main activities, the company is expensive. -2
- The MRQ is -3.481. Based on how much money comes from the company's main activities, the company is expensive. -2
- The TTM is -3.481. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
- The YOY is -5.943. Compared to the TTM, the mid term is trending up. -2
- The 5Y is -160.714. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is -73.481. Compared to the 5Y term, the 10Y term is trending down. +2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| EOD | -3.256 | MRQ | -3.481 | +0.225 | |
| MRQ | -3.481 | TTM | -3.481 | 0.000 | |
| TTM | -3.481 | YOY | -5.943 | +2.461 | |
| TTM | -3.481 | 5Y | -160.714 | +157.233 | |
| 5Y | -160.714 | 10Y | -73.481 | -87.233 | |
Compared to industry (Medical Devices)
Let compare the company's priceToFreeCashFlowRatio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -1.578. trending down. +2
- The TTM average (mean) in the Medical Devices industry is -2.973. trending down. +2
2. Book Value per Share
2.3. Price to Book Ratio
Measures if the stock price of STRATA Skin Sciences Inc is to cheap or to expensive compared to its book value.
- At or below 1 is considered healthy (always compare to Medical Devices industry mean).
- A PB ratio of 1.52 means the investor is paying $1.52 for each $1 in book value.
Let's take a look of the Price to Book Ratio trends of STRATA Skin Sciences Inc:
Trends
- The YOY is 1.268. Compared to the TTM, the mid term is trending up. -2
- The 5Y is 1.834. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 2.092. Compared to the 5Y term, the 10Y term is trending down. +2
| Current period | Compared to | +/- | |||
|---|---|---|---|---|---|
| EOD | 1.421 | MRQ | 1.520 | -0.098 | |
| MRQ | 1.520 | TTM | 1.520 | 0.000 | |
| TTM | 1.520 | YOY | 1.268 | +0.251 | |
| TTM | 1.520 | 5Y | 1.834 | -0.315 | |
| 5Y | 1.834 | 10Y | 2.092 | -0.257 | |
Compared to industry (Medical Devices)
Let compare the company's Price to Book Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 2.372. trending down. +2
- The TTM average (mean) in the Medical Devices industry is 2.444. trending down. +2
2. Total Gains per Share
3. Holders & Insider Transactions
Let's take a look at which institutions, funds and insiders are holding shares of STRATA Skin Sciences Inc.
3.1. Institutions holding STRATA Skin Sciences Inc
Institutions are holding 66.993% of the shares of STRATA Skin Sciences Inc.
| Date | Name | Total Shares | Total Assets | Current Shares | Change | % |
|---|---|---|---|---|---|---|
| 2023-12-31 | Nantahala Capital Management, LLC | 17.8501 | 0.1029 | 6256264 | 2991319 | 91.6193 |
| 2023-12-31 | 22NW, LP | 15.3213 | 1.9242 | 5369954 | 0 | 0 |
| 2023-12-31 | Renaissance Technologies Corp | 3.0456 | 0.0009 | 1067453 | -11700 | -1.0842 |
| 2023-12-31 | Vanguard Group Inc | 2.4486 | 0 | 858202 | 0 | 0 |
| 2023-12-31 | Cannell Capital LLC | 0.7869 | 0.0329 | 275806 | -75805 | -21.5593 |
| 2023-12-31 | Goldman Sachs Group Inc | 0.3768 | 0 | 132058 | 66033 | 100.0121 |
| 2023-12-31 | Geode Capital Management, LLC | 0.3156 | 0 | 110621 | 0 | 0 |
| 2023-12-31 | Creative Planning Inc | 0.2858 | 0.0001 | 100160 | 150 | 0.15 |
| 2023-12-31 | Perritt Capital Management Inc. | 0.2853 | 0.0308 | 100000 | 0 | 0 |
| 2023-12-31 | BlackRock Inc | 0.278 | 0 | 97436 | -1739 | -1.7535 |
| 2023-12-31 | We Are One Seven, LLC | 0.2038 | 0.0023 | 71420 | 0 | 0 |
| 2023-12-31 | Chicago Partners Investment Group LLC | 0.1832 | 0.0015 | 64223 | 39706 | 161.9529 |
| 2023-09-30 | PNC Financial Services Group Inc | 0.0905 | 0 | 31733 | 0 | 0 |
| 2023-12-31 | Northern Trust Corp | 0.0775 | 0 | 27170 | 0 | 0 |
| 2023-12-31 | State Street Corporation | 0.0327 | 0 | 11450 | 0 | 0 |
| 2023-12-31 | Tower Research Capital LLC | 0.0308 | 0.0001 | 10798 | 5657 | 110.037 |
| 2023-12-31 | Carmichael Hill & Associates Inc | 0.0086 | 0.0007 | 3000 | 0 | 0 |
| 2023-12-31 | JPMorgan Chase & Co | 0.0018 | 0 | 634 | 609 | 2436 |
| 2023-12-31 | Morgan Stanley - Brokerage Accounts | 0.0015 | 0 | 510 | 0 | 0 |
| 2023-12-31 | Royal Bank of Canada | 0.0009 | 0 | 320 | 272 | 566.6667 |
| Total | 41.6253 | 2.0964 | 14589212 | +3014502 | +20.7% |
3.2. Funds holding STRATA Skin Sciences Inc
| Date | Name | Total Shares | Total Assets | Current Shares | Change | % |
|---|---|---|---|---|---|---|
| 2024-02-29 | Vanguard Total Stock Mkt Idx Inv | 1.692 | 0 | 593248 | 0 | 0 |
| 2024-02-29 | Vanguard Institutional Extnd Mkt Idx Tr | 0.6716 | 0.0001 | 235454 | 0 | 0 |
| 2023-12-31 | Perritt Ultra MicroCap | 0.2852 | 0.4967 | 100000 | 0 | 0 |
| 2024-02-29 | Fidelity Extended Market Index | 0.2494 | 0.0001 | 87443 | -424 | -0.4825 |
| 2024-03-28 | iShares Micro-Cap ETF | 0.1187 | 0.0017 | 41607 | 0 | 0 |
| 2023-10-31 | Vanguard Instl Ttl Stck Mkt Idx Tr | 0.0604 | 0 | 21171 | -572077 | -96.4313 |
| 2024-02-29 | Vanguard Instl Ttl Stk Mkt Idx InstlPls | 0.0604 | 0 | 21171 | 0 | 0 |
| 2023-12-31 | NT Ext Equity Mkt Idx Fd - L | 0.0562 | 0.0002 | 19716 | 0 | 0 |
| 2023-12-31 | Northern Trust Extended Eq Market Idx | 0.0562 | 0.0002 | 19716 | 0 | 0 |
| 2024-02-29 | Fidelity Nasdaq Composite Index | 0.0498 | 0.0001 | 17447 | 0 | 0 |
| 2024-02-29 | Fidelity Series Total Market Index | 0.038 | 0 | 13340 | 0 | 0 |
| 2024-02-29 | Vanguard Balanced Index Inv | 0.0238 | 0 | 8329 | 0 | 0 |
| 2023-09-30 | BlackRock Extended Mkt Composite | 0.0176 | 0 | 6179 | 0 | 0 |
| 2023-12-31 | NT Ext Equity Mkt Idx Fd - NL | 0.0161 | 0.0001 | 5652 | 0 | 0 |
| 2024-03-31 | BlackRock Extended Equity Market K | 0.0154 | 0 | 5393 | 2 | 0.0371 |
| 2023-12-31 | NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 0.0129 | 0.0001 | 4539 | 9 | 0.1987 |
| 2024-02-29 | 1290 VT Micro Cap K | 0.0111 | 0.0013 | 3895 | 0 | 0 |
| 2024-02-29 | Spartan Extended Market Index Pool E | 0.0065 | 0.0001 | 2279 | 424 | 22.8571 |
| 2023-12-31 | Northern Trust Wilshire 5000 | 0.0048 | 0 | 1683 | 0 | 0 |
| 2023-12-31 | NT US Market Cap Idx Fd - L | 0.0048 | 0 | 1683 | 0 | 0 |
| Total | 3.4509 | 0.5007 | 1209945 | -572066 | -47.3% |
3.3. Insider Transactions
4. Summary
4.1. Key Performance Indicators
The key performance indicators of STRATA Skin Sciences Inc compared to the Most Recent Quarter (MRQ).
| End of day | +/- | Most Recent Quarter | Trailing 12 Months | +/- | Year-Over-Year | +/- | 5 Year | +/- | 10 Year | +/- | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value Change Per Share | - | - | -0.261 | -0.261 | 0% | -0.102 | -61% | -0.106 | -59% | 0.013 | -2182% |
| Book Value Per Share | - | - | 0.362 | 0.362 | 0% | 0.623 | -42% | 0.668 | -46% | 0.610 | -41% |
| Current Ratio | - | - | 1.277 | 1.277 | 0% | 1.304 | -2% | 1.631 | -22% | 2.217 | -42% |
| Debt To Asset Ratio | - | - | 0.698 | 0.698 | 0% | 0.582 | +20% | 0.505 | +38% | 0.502 | +39% |
| Debt To Equity Ratio | - | - | 2.311 | 2.311 | 0% | 1.394 | +66% | 1.173 | +97% | 1.189 | +94% |
| Dividend Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% |
| Eps | - | - | -0.309 | -0.309 | 0% | -0.158 | -49% | -0.155 | -50% | -0.274 | -11% |
| Free Cash Flow Per Share | - | - | -0.158 | -0.158 | 0% | -0.133 | -16% | -0.064 | -59% | -0.098 | -38% |
| Free Cash Flow To Equity Per Share | - | - | 0.038 | 0.038 | 0% | -0.147 | +490% | 0.052 | -27% | 0.184 | -80% |
| Gross Profit Margin | - | - | 2.196 | 2.196 | 0% | 3.757 | -42% | 3.696 | -41% | 3.091 | -29% |
| Intrinsic Value_10Y_max | - | - | 1.890 | - | - | - | - | - | - | - | - |
| Intrinsic Value_10Y_min | - | - | -2.789 | - | - | - | - | - | - | - | - |
| Intrinsic Value_1Y_max | - | - | -0.010 | - | - | - | - | - | - | - | - |
| Intrinsic Value_1Y_min | - | - | -0.160 | - | - | - | - | - | - | - | - |
| Intrinsic Value_3Y_max | - | - | 0.123 | - | - | - | - | - | - | - | - |
| Intrinsic Value_3Y_min | - | - | -0.587 | - | - | - | - | - | - | - | - |
| Intrinsic Value_5Y_max | - | - | 0.438 | - | - | - | - | - | - | - | - |
| Intrinsic Value_5Y_min | - | - | -1.127 | - | - | - | - | - | - | - | - |
| Market Cap | 18032607.600 | -7% | 19280344.880 | 19280344.880 | 0% | 27692056.880 | -30% | 44758719.552 | -57% | 45441470.176 | -58% |
| Net Profit Margin | - | - | -0.325 | -0.325 | 0% | -0.153 | -53% | -0.179 | -45% | -2.085 | +542% |
| Operating Margin | - | - | -0.189 | -0.189 | 0% | -0.126 | -33% | -0.157 | -17% | -1.579 | +733% |
| Operating Ratio | - | - | 1.189 | 1.189 | 0% | 1.129 | +5% | 1.151 | +3% | 3.011 | -61% |
| Pb Ratio | 1.421 | -7% | 1.520 | 1.520 | 0% | 1.268 | +20% | 1.834 | -17% | 2.092 | -27% |
| Pe Ratio | -1.665 | +6% | -1.780 | -1.780 | 0% | -4.990 | +180% | -11.586 | +551% | -10.019 | +463% |
| Price Per Share | 0.515 | -7% | 0.550 | 0.550 | 0% | 0.790 | -30% | 1.277 | -57% | 1.297 | -58% |
| Price To Free Cash Flow Ratio | -3.256 | +6% | -3.481 | -3.481 | 0% | -5.943 | +71% | -160.714 | +4516% | -73.481 | +2011% |
| Price To Total Gains Ratio | -1.972 | +6% | -2.109 | -2.109 | 0% | -7.729 | +267% | -31.768 | +1406% | -11.302 | +436% |
| Quick Ratio | - | - | 1.032 | 1.032 | 0% | 0.738 | +40% | 1.209 | -15% | 1.592 | -35% |
| Return On Assets | - | - | -0.258 | -0.258 | 0% | -0.106 | -59% | -0.120 | -53% | -0.266 | +3% |
| Return On Equity | - | - | -0.854 | -0.854 | 0% | -0.254 | -70% | -0.303 | -65% | -0.588 | -31% |
| Total Gains Per Share | - | - | -0.261 | -0.261 | 0% | -0.102 | -61% | -0.106 | -59% | 0.013 | -2182% |
| Usd Book Value | - | - | 12688000.000 | 12688000.000 | 0% | 21831000.000 | -42% | 23414600.000 | -46% | 21364800.000 | -41% |
| Usd Book Value Change Per Share | - | - | -0.261 | -0.261 | 0% | -0.102 | -61% | -0.106 | -59% | 0.013 | -2182% |
| Usd Book Value Per Share | - | - | 0.362 | 0.362 | 0% | 0.623 | -42% | 0.668 | -46% | 0.610 | -41% |
| Usd Dividend Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% |
| Usd Eps | - | - | -0.309 | -0.309 | 0% | -0.158 | -49% | -0.155 | -50% | -0.274 | -11% |
| Usd Free Cash Flow | - | - | -5538000.000 | -5538000.000 | 0% | -4660000.000 | -16% | -2254400.000 | -59% | -3440600.000 | -38% |
| Usd Free Cash Flow Per Share | - | - | -0.158 | -0.158 | 0% | -0.133 | -16% | -0.064 | -59% | -0.098 | -38% |
| Usd Free Cash Flow To Equity Per Share | - | - | 0.038 | 0.038 | 0% | -0.147 | +490% | 0.052 | -27% | 0.184 | -80% |
| Usd Market Cap | 18032607.600 | -7% | 19280344.880 | 19280344.880 | 0% | 27692056.880 | -30% | 44758719.552 | -57% | 45441470.176 | -58% |
| Usd Price Per Share | 0.515 | -7% | 0.550 | 0.550 | 0% | 0.790 | -30% | 1.277 | -57% | 1.297 | -58% |
| Usd Profit | - | - | -10830000.000 | -10830000.000 | 0% | -5549000.000 | -49% | -5506000.000 | -49% | -10035300.000 | -7% |
| Usd Revenue | - | - | 33357999.000 | 33357999.000 | 0% | 36161000.000 | -8% | 30488199.800 | +9% | 26491199.900 | +26% |
| Usd Total Gains Per Share | - | - | -0.261 | -0.261 | 0% | -0.102 | -61% | -0.106 | -59% | 0.013 | -2182% |
| EOD | +3 -5 | MRQ | TTM | +0 -0 | YOY | +5 -29 | 5Y | +4 -30 | 10Y | +8 -26 |
4.2. Fundamental Score
Let's check the fundamental score of STRATA Skin Sciences Inc based on Penke's default stock scanner.
Penke's Stock Scanner
| Indicator | Condition | Value | ||
|---|---|---|---|---|
| Price to Earnings Ratio (EOD) | Between | 0-15 | -1.665 | |
| Price to Book Ratio (EOD) | Between | 0-1 | 1.421 | |
| Net Profit Margin (MRQ) | Greater than | 0 | -0.325 | |
| Operating Margin (MRQ) | Greater than | 0 | -0.189 | |
| Quick Ratio (MRQ) | Greater than | 1 | 1.032 | |
| Current Ratio (MRQ) | Greater than | 1 | 1.277 | |
| Debt to Asset Ratio (MRQ) | Less than | 1 | 0.698 | |
| Debt to Equity Ratio (MRQ) | Less than | 1 | 2.311 | |
| Return on Equity (MRQ) | Greater than | 0.15 | -0.854 | |
| Return on Assets (MRQ) | Greater than | 0.05 | -0.258 | |
| Total | 3/10 (30.0%) | |||
4.3. Technical Score
Let's check the technical score of STRATA Skin Sciences Inc based on Penke's default Symbol scanner.
Penke's Symbol Scanner
| Indicator | Condition | Value | ||
|---|---|---|---|---|
| Rsi | Greater than | 50 | 51.062 | |
| Ma 20 | Greater than | Ma 50 | 0.503 | |
| Ma 50 | Greater than | Ma 100 | 0.501 | |
| Ma 100 | Greater than | Ma 200 | 0.525 | |
| Open | Greater than | Close | 0.529 | |
| Total | 3/5 (60.0%) | |||
Latest Balance Sheet
Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.
Summary
| As reported | |
|---|---|
| Total Liabilities | 29,328 |
| Total Stockholder Equity | + 12,688 |
| Total Assets | = 42,016 |
Assets
Total Current Assets
Long-term Assets
| Property Plant Equipment | 12,404 |
| Goodwill | 6,519 |
| Intangible Assets | 7,319 |
| Long-term Assets Other | 231 |
| Long-term Assets (as reported) | 26,473 |
|---|---|
| Long-term Assets (calculated) | 26,473 |
| +/- | 0 |
Liabilities & Shareholders' Equity
Total Current Liabilities
Long-term Liabilities
Total Stockholder Equity
| Common Stock | 35 |
| Retained Earnings | -238,058 |
| Other Stockholders Equity | 250,711 |
| Total Stockholder Equity (as reported) | 12,688 |
|---|---|
| Total Stockholder Equity (calculated) | 12,688 |
| +/- | 0 |
Other
Balance Sheet
Currency in USD. All numbers in thousands.
| Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 | 2000-12-31 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| > Total Assets |
| 42,016 | 52,272 | 46,593 | 46,778 | 47,507 | 47,507 | 38,631 | 43,193 | 51,372 | 20,070 | 14,132 | 17,270 | 31,393 | 33,589 | 32,127 | 16,620 | 22,108 | 22,476 | 19,166 | 7,096 | 432 | 344 | 1,131 | 3,814 | ||||||||||||||||||||||||
| > Total Current Assets |
| 15,543 | 17,504 | 19,970 | 24,831 | 23,210 | 23,210 | 10,752 | 10,752 | 11,979 | 17,203 | 10,351 | 9,683 | 29,058 | 31,044 | 30,338 | 15,836 | 21,328 | 21,771 | 18,873 | 6,813 | 217 | 111 | 867 | 3,513 | ||||||||||||||||||||||||
| Cash And Cash Equivalents |
| 8,118 | 5,434 | 12,586 | 10,604 | 16,487 | 16,487 | 4,069 | 3,928 | 3,303 | 11,434 | 3,783 | 7,862 | 27,997 | 30,521 | 29,673 | 15,070 | 19,197 | 20,940 | 18,505 | 109 | 120 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Short-term Investments |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 391 | 1,720 | 0 | 0 | 6,595 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Net Receivables |
| 4,440 | 4,471 | 3,433 | 2,944 | 3,393 | 3,393 | 3,141 | 3,390 | 4,068 | 220 | 57 | 180 | 0 | 0 | 0 | 0 | 0 | 488 | 0 | 7 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Other Current Assets |
| 312 | 691 | 462 | 331 | 536 | 536 | 533 | 617 | 465 | 274 | 880 | 966 | 1,062 | 524 | 665 | 376 | 412 | 344 | 157 | 33 | 97 | 111 | 0 | 0 | ||||||||||||||||||||||||
| > Long-term Assets |
| 26,473 | 34,768 | 26,623 | 21,947 | 24,297 | 24,297 | 27,879 | 32,441 | 39,393 | 2,867 | 3,781 | 7,587 | 2,335 | 2,545 | 1,789 | 784 | 780 | 705 | 293 | 283 | 215 | 233 | 264 | 301 | ||||||||||||||||||||||||
| Property Plant Equipment |
| 12,404 | 8,473 | 7,521 | 6,517 | 5,301 | 5,301 | 7,703 | 10,180 | 13,851 | 1,961 | 3,691 | 7,350 | 1,627 | 2,074 | 1,572 | 643 | 616 | 564 | 175 | 89 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Goodwill |
| 6,519 | 8,803 | 8,803 | 8,803 | 8,803 | 8,803 | 8,803 | 8,803 | 8,928 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Intangible Assets |
| 7,319 | 17,394 | 10,083 | 6,345 | 9,765 | 9,765 | 11,325 | 13,412 | 15,227 | 37 | 42 | 47 | 59 | 71 | 83 | 95 | 118 | 101 | 84 | 163 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Other Assets |
| 0 | 0 | 216 | 1,270 | 347 | 428 | 48 | 46 | 94 | 869 | 48 | 190 | 648 | 400 | 134 | 46 | 46 | 40 | 34 | 30 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| > Total Liabilities |
| 29,328 | 30,441 | 21,179 | 20,886 | 16,259 | 16,259 | 16,386 | 28,474 | 35,285 | 7,794 | 5,836 | 3,295 | 1,586 | 1,790 | 1,811 | 1,530 | 1,336 | 1,162 | 916 | 10,646 | 650 | 5,001 | 0 | 0 | ||||||||||||||||||||||||
| > Total Current Liabilities |
| 12,174 | 13,426 | 12,802 | 18,838 | 8,615 | 8,615 | 7,672 | 6,133 | 6,780 | 2,686 | 5,652 | 3,019 | 1,448 | 1,686 | 1,811 | 1,530 | 1,336 | 1,162 | 916 | 691 | 650 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Short-term Debt |
| 352 | 355 | 318 | 9,122 | 252 | 252 | 2,744 | 2,053 | 299 | 842 | 844 | 957 | 0 | 0 | 0 | 832 | -74,196 | 0 | 0 | 229 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Short Long Term Debt |
| 0 | 0 | 0 | 8,753 | 7,275 | 252 | 2,744 | 2,053 | 19,989 | 5,001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Accounts payable |
| 3,343 | 3,425 | 2,822 | 2,764 | 1,764 | 6,264 | 4,637 | 3,845 | 6,607 | 1,240 | 1,479 | 1,850 | 671 | 1,097 | 1,187 | 634 | 568 | 641 | 329 | 339 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Other Current Liabilities |
| 6,359 | 6,868 | 6,377 | 4,690 | 4,500 | 2,099 | 2,360 | 1,992 | -299 | 561 | 3,085 | 41 | 777 | 590 | 624 | 27 | 19 | 521 | 587 | 17 | 650 | 0 | 0 | 0 | ||||||||||||||||||||||||
| > Long-term Liabilities |
| 17,154 | 17,015 | 8,377 | 2,048 | 7,644 | 7,644 | 8,714 | 22,341 | 28,505 | 5,108 | 184 | 275 | 138 | 104 | 0 | 0 | 0 | 0 | 0 | 9,955 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Long term Debt Total |
| 0 | 0 | 0 | 1,050 | 0 | 7,145 | 7,853 | 21,780 | 19,690 | 5,001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Other Liabilities |
| 0 | 0 | 666 | 288 | 178 | 499 | 925 | 561 | 7,223 | 606 | 184 | 276 | 138 | 104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Deferred Long Term Liability |
| 0 | 0 | 0 | 254 | 0 | 111 | 417 | 464 | 0 | 107 | 64 | 275 | 138 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| > Total Stockholder Equity |
| 12,688 | 21,831 | 25,414 | 25,892 | 31,248 | 31,248 | 22,245 | 14,719 | 16,087 | 12,276 | 8,296 | 13,975 | 29,807 | 31,799 | 30,316 | 15,089 | 20,772 | 21,314 | 18,249 | -3,550 | -218 | -4,657 | -3,408 | -4,148 | ||||||||||||||||||||||||
| Common Stock |
| 35 | 35 | 34 | 34 | 30 | 30 | 4 | 11 | 10 | 6 | 48 | 32 | 30 | 25 | 22 | 18 | 15 | 13 | 11 | 2 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Retained Earnings | -238,058 | -227,228 | -221,679 | -218,973 | -210,771 | -210,771 | -229,406 | -210,575 | -207,240 | -182,293 | -168,148 | -142,200 | -119,527 | -99,143 | -79,220 | -60,767 | -43,162 | -31,225 | -20,633 | -13,907 | -10,288 | -8,518 | -7,197 | -4,148 | |||||||||||||||||||||||||
| Capital Surplus |
| 0 | 0 | 0 | 244,831 | 243,180 | 241,988 | 251,643 | 225,280 | 223,315 | 194,562 | 0 | 156,143 | 149,304 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
| Other Stockholders Equity |
| 250,711 | 249,024 | 247,059 | 244,831 | 255,520 | 0 | 262,377 | 225,280 | 223,315 | 199,754 | 181,799 | 159,112 | 151,316 | 132,377 | 110,458 | 76,678 | 64,115 | 52,722 | 39,069 | 9,611 | 10,070 | 3,861 | 3,789 | 0 |
Balance Sheet
Currency in USD. All numbers in thousands.
Cash Flow
Currency in USD. All numbers in thousands.
Income Statement
Currency in USD. All numbers in thousands.
Latest Income Statement (annual, 2023-12-31)
| Gross Profit (+$) | ||
|---|---|---|
| totalRevenue | 33,358 | |
| Cost of Revenue | -14,897 | |
| Gross Profit | 18,461 | 18,461 |
| Operating Income (+$) | ||
| Gross Profit | 18,461 | |
| Operating Expense | -24,781 | |
| Operating Income | -6,320 | -6,320 |
| Operating Expense (+$) | ||
| Research Development | 1,317 | |
| Selling General Administrative | 10,508 | |
| Selling And Marketing Expenses | 12,956 | |
| Operating Expense | 24,781 | 24,781 |
| Net Interest Income (+$) | ||
| Interest Income | 192 | |
| Interest Expense | -1,640 | |
| Other Finance Cost | -253 | |
| Net Interest Income | -1,195 | |
| Pretax Income (+$) | ||
| Operating Income | -6,320 | |
| Net Interest Income | -1,195 | |
| Other Non-Operating Income Expenses | 0 | |
| Income Before Tax (EBT) | -10,922 | -1,718 EBIT - interestExpense = -7,960 -10,922 -9,190 |
| Interest Expense | 1,640 | |
| Earnings Before Interest and Taxes (EBIT) | -6,320 | -9,282 |
| Earnings Before Interest and Taxes (EBITDA) | -418 | |
| After tax Income (+$) | ||
| Income Before Tax | -10,922 | |
| Tax Provision | --92 | |
| Net Income From Continuing Ops | -7,196 | -10,830 |
| Net Income | -10,830 | |
| Net Income Applicable To Common Shares | 0 | |
| Non-recurring Events | ||
| Discontinued Operations | 0 | |
| Extraordinary Items | 0 | |
| Effect of Accounting Charges | 0 | |
| Other Items | 0 | |
| Non Recurring | 0 | |
| Other Operating Expenses | 39,678 | |
| Total Other Income/Expenses Net | -4,602 | 1,195 |
Technical Analysis of STRATA Skin Sciences Inc
The psychology behind the price
Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.
General trend
First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of STRATA Skin Sciences Inc. The general trend of STRATA Skin Sciences Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine STRATA Skin Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.
Indicator phases
Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:
| Indicator zone transitions | Bullish trend (-28.6%) | Bearish trend (28.6%) | |
|---|---|---|---|
| Overbought to neutral | Bullish pullback | = | Bearish reversal |
| Upper to lower neutral | Bullish correction | = | Bearish continuation |
| Nuetral to oversold | Oversold | = | Oversold |
| Oversold to neutral | Bullish reversal | = | Bearish correction |
| Lower to upper neutral | Bullish continuation | = | Bearish pullback |
| Nuetral to overbought | Overbought | = | Overbought |
1. Price Targets
1.1 Support & Resistance
Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.
Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.
Score
Let's take a look at the Support & Resistance of STRATA Skin Sciences Inc.
The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).
- Between support/resistance: The price is trading between support and resistance lines.
The bullish price targets are: 0.5879 < 0.589 < 0.59.
The bearish price targets are: 0.455 > 0.36 > 0.262.
Tweet this
2. Trend Indicators
2.1 Moving Averages
Shows the moving average of the selected period.
- Moving averages are lagging trend indicators.
- There are many types of moving averages.
- Moving averages are also used within other indicators.
Score
Let's take a look at the Moving Averages of STRATA Skin Sciences Inc. The current mas is .
The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).
- MA 20 trending up: The MA 20 is trending up. +1
- Close > MA 20: The price is above the MA 20. +1
- MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
- MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
- MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
- MA 50 trending down: The MA 50 is trending down. -1
- Close > MA 50: The price is above the MA 50. +1
- MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
- MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
- MA 100 trending up: The MA 100 is trending up. +1
- Close < MA 100: The price is below the MA 100. -1
- MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
- MA 200 trending down: The MA 200 is trending down. -1
- Close < MA 200: The price is below the MA 200. -1
Directionalities and relatives.
| Moving Average | Amount of candles | Trend | Price +/- | vs. MA 50 | vs. MA 100 | vs. MA 200 |
|---|---|---|---|---|---|---|
| MA 20 | 20 | |||||
| MA 50 | 50 | - | ||||
| MA 100 | 100 | - | - | |||
| MA 200 | 200 | - | - | - |
Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I
2.2 Moving Average Convergence/Divergence (MACD)
Shows the momentum of the selected period based on two moving averages.
- MACD is a lagging momentum indicator.
- Uses two moving averages.
- Can show buy or sell signals based on momentum.
- Can show overbought. and oversold. levels.
Score
Let's take a look at the Moving Average Convergence/Divergence (MACD) of STRATA Skin Sciences Inc. The current macd is 0.01221717.
The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).
- MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the STRATA Skin Sciences Inc price going up in the near term. +2
- MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for STRATA Skin Sciences Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the STRATA Skin Sciences Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
- Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
2.3 Directional Movement Index (DMI)
The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.
Score
Let's take a look at the Directional Movement Index (DMI) of STRATA Skin Sciences Inc. The current adx is 22.79.
The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).
- PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy STRATA Skin Sciences Inc shares, leading to potential upward momentum in its price. +1
- PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
2.4 Parabolic SAR
Shows the current trend and potential entry and exit signals.
- Parabolic SAR (stop and reverse) is a lagging trend indicator.
- Shows the current trend.
- Shows potential entry signals.
- Shows potential exit signals.
- Can be used to place trailing stoplosses..
Score
Let's take a look at the Parabolic SAR of STRATA Skin Sciences Inc. The current sar is 0.59.
The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).
- Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
3. Momentum Indicators
3.1 Relative Strength Index (RSI)
Measures the speed and change of price movements.
- Leading momentum indicator, meaning the signals are instant.
- Ranges between 0 and 100.
- Above 70 is considered overbought.
- Below 30 is considered oversold.
- Above or below 50 can also be used to determine price trend or support and resistance.
- RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
- Can be used in many different ways
Score
Let's take a look at the Relative Strength Index (RSI) of STRATA Skin Sciences Inc. The current rsi is 51.06. The current phase is Correction in bear market.
The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).
- Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
- Trending down: The RSI is trending down. -1
3.2 Stochastic Oscillator
Compares a certain price to multiple prices ranging over time.
- Leading momentum indicator, meaning the signals are instant.
- Used to determine overbought and oversold areas much like the RSI.
- Ranges between 0 and 100.
- Above 80 is considered overbought.
- Below 20 is considered oversold.
- Consists of two lines named K and D.
- K compares the highest high and lowest low on the selected price range.
- The D line is a moving average of the K line.
- Can be used to spot divergences
Score
Let's take a look at the Stochastic Oscillator of STRATA Skin Sciences Inc. The current phase is Continuation in bear market.
The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).
- STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
- STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the STRATA Skin Sciences Inc price going down in the near term. -2
- Trending down: The STOCH %K is trending down. -1
3.3 Commodity Channel Index (CCI)
Measures the difference between the current price and the historical average price.
- Lagging or leading Momentum indicator
- When the CCI is above zero, the price is above the historical average
- When the CCI is below zero, the price is below the historical average
- Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend
Score
Let's take a look at the Commodity Channel Index (CCI) of STRATA Skin Sciences Inc. The current cci is 27.20.
3.4 Chande Momentum Oscillator (CMO)
Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.
- Lagging momentum indicator
- Ranges between +100 and -100
- Considered overbought above +50
- Considered oversold below -50
- It's possible to add a moving average that acts as a signal line
Score
Let's take a look at the Chande Momentum Oscillator (CMO) of STRATA Skin Sciences Inc. The current cmo is -0.50122917.
The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).
- CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
3.5 Williams %R
Shows the current price relative to the highest high over the last 14 days.
- Lagging momentum indicator
- Ranging between 0 and -100
- Above -20 is considered overbought
- Below -80 is considered oversold
- Is prone to give false signals
Score
Let's take a look at the Williams %R of STRATA Skin Sciences Inc. The current willr is -55.92592593.
The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).
- WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that STRATA Skin Sciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
4. Volatility Indicators
4.1 Bollinger Bands
Shows if the price is to high or to low relative to an average.
- Lagging volatility indicator
- Uses 3 bands: one upper, one lower and one in the middle
- Works best when the middle band reflects an intermediate trend (MA20).
- When the price is moving closer to the upper band, the market might be overbought
- When the price is moving closer to the lower band, the market might be oversold
Score
Let's take a look at the Bollinger Bands of STRATA Skin Sciences Inc.
4.2 Average True Range (ATR)
Measures market volatility
- Leading volatility indicator
- Can be used to determine stop-loss positions
- Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
- The larger the range of the candles, the greater the ATR value
Score
Let's take a look at the Average True Range (ATR) of STRATA Skin Sciences Inc. The current atr is 0.05093061.
5. Volume Indicators
5.1 On-Balance Volume (OBV)
Measures market volatility
- Leading momentum indicator
- Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
- Can be used to confirm price trends
- Can be used with divergences
Score
Let's take a look at the On-Balance Volume (OBV) of STRATA Skin Sciences Inc. The current obv is 10,636,885.
5.2 Money Flow Index (MFI)
Measures the flow of money in and out of a security
- Lagging momentum indicator
- Looks like RSI but uses volume as an extra metric (RSI only considers price)
- Above 80 is considered overbought
- Below 20 is considered oversold
- Can be used with divergences
Score
Let's take a look at the Money Flow Index (MFI) of STRATA Skin Sciences Inc. The current mfi is 79.87.
The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).
- MFI > 50: +1
6. Summary
6.1. Notifications
| Type | Notification | Date |
|---|---|---|
 Currently no notifications for STRATA Skin Sciences Inc. |
6.2. Trading Signals
Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.
| Date | Indicator | Signal | ||
|---|---|---|---|---|
| 2023-12-05 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2023-12-07 | CCI | LONG ENTRY | SHORT CLOSE | 100 crossover to upside |
| BB | SHORT ENTRY | LONG CLOSE | Price closed above the lower band. | |
| ATR | LONG ENTRY | SHORT CLOSE | Price closed above (close + ATR). | |
| 2023-12-08 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2023-12-13 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2023-12-15 | CCI | LONG ENTRY | SHORT CLOSE | 100 crossover to upside |
| 2023-12-18 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2023-12-19 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2023-12-21 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| MFI | LONG ENTRY | SHORT CLOSE | 80 crossover to upside | |
| 2023-12-22 | MFI | SHORT ENTRY | LONG CLOSE | 80 crossover to downside |
| 2023-12-27 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| SAR | SHORT ENTRY | LONG CLOSE | The price broke the SAR to the downside | |
| 2023-12-28 | MACD | SHORT ENTRY | LONG CLOSE | The MACD line crosses below the signal line. |
| DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2023-12-29 | MFI | LONG ENTRY | SHORT CLOSE | 80 crossover to upside |
| 2024-01-02 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| STOCH | SHORT EXIT | The %K line crosses above the %D line. | ||
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| 2024-01-03 | CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside |
| 2024-01-04 | DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. |
| 2024-01-05 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2024-01-08 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2024-01-09 | WILLR | LONG ENTRY | SHORT CLOSE | -20 crossover to upside |
| 2024-01-10 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2024-01-11 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2024-01-12 | DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. |
| STOCH | SHORT EXIT | The %K line crosses above the %D line. | ||
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2024-01-16 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| 2024-01-17 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2024-01-18 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2024-01-23 | CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| 2024-01-26 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2024-01-29 | CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside |
| 2024-01-30 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2024-01-31 | DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. |
| SAR | LONG ENTRY | SHORT CLOSE | The price broke the SAR to the upside. | |
| 2024-02-01 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| 2024-02-02 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2024-02-05 | DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. |
| 2024-02-06 | MACD | LONG ENTRY | SHORT CLOSE | The MACD line crosses above the signal line. |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2024-02-08 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2024-02-09 | CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside |
| 2024-02-13 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2024-02-15 | MACD | SHORT ENTRY | LONG CLOSE | The MACD line crosses below the signal line. |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| 2024-02-20 | SAR | SHORT ENTRY | LONG CLOSE | The price broke the SAR to the downside |
| STOCH | SHORT EXIT | The %K line crosses above the %D line. | ||
| 2024-02-23 | CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside |
| 2024-02-26 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2024-02-28 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2024-02-29 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2024-03-01 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2024-03-05 | MACD | LONG ENTRY | SHORT CLOSE | The MACD line crosses above the signal line. |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| WILLR | LONG ENTRY | SHORT CLOSE | -20 crossover to upside | |
| 2024-03-06 | DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. |
| SAR | LONG ENTRY | SHORT CLOSE | The price broke the SAR to the upside. | |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| 2024-03-08 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2024-03-11 | CCI | LONG ENTRY | SHORT CLOSE | 100 crossover to upside |
| 2024-03-12 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2024-03-13 | WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside |
| 2024-03-14 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2024-03-15 | MACD | SHORT ENTRY | LONG CLOSE | The MACD line crosses below the signal line. |
| SAR | SHORT ENTRY | LONG CLOSE | The price broke the SAR to the downside | |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| 2024-03-18 | CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside |
| 2024-03-19 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2024-03-22 | CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside |
| 2024-03-25 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| 2024-03-26 | BB | LONG ENTRY | SHORT CLOSE | Price closed below the lower band. |
| 2024-03-27 | MFI | SHORT ENTRY | LONG CLOSE | 20 crossover to downside |
| 2024-03-28 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| STOCH | SHORT EXIT | The %K line crosses above the %D line. | ||
| ATR | SHORT ENTRY | LONG CLOSE | Price closed below (close - ATR). | |
| 2024-04-01 | RSI | LONG ENTRY | SHORT CLOSE | 30 crossover to upside |
| 2024-04-02 | SAR | LONG ENTRY | SHORT CLOSE | The price broke the SAR to the upside. |
| ATR | LONG ENTRY | SHORT CLOSE | Price closed above (close + ATR). | |
| MFI | LONG ENTRY | SHORT CLOSE | 20 crossover to upside | |
| 2024-04-04 | DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| ATR | LONG ENTRY | SHORT CLOSE | Price closed above (close + ATR). | |
| 2024-04-05 | MACD | LONG ENTRY | SHORT CLOSE | The MACD line crosses above the signal line. |
| 2024-04-08 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2024-04-10 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| WILLR | LONG ENTRY | SHORT CLOSE | -20 crossover to upside | |
| 2024-04-11 | CCI | LONG ENTRY | SHORT CLOSE | 100 crossover to upside |
| 2024-04-12 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2024-04-15 | CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside |
| 2024-04-16 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2024-04-17 | WILLR | LONG ENTRY | SHORT CLOSE | -20 crossover to upside |
| 2024-04-18 | CCI | LONG ENTRY | SHORT CLOSE | 100 crossover to upside |
| MFI | LONG ENTRY | SHORT CLOSE | 80 crossover to upside | |
| 2024-04-19 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2024-04-22 | MFI | SHORT ENTRY | LONG CLOSE | 80 crossover to downside |
| 2024-04-23 | MFI | LONG ENTRY | SHORT CLOSE | 80 crossover to upside |
| 2024-04-24 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2024-04-25 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2024-04-26 | SAR | SHORT ENTRY | LONG CLOSE | The price broke the SAR to the downside |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| MFI | SHORT ENTRY | LONG CLOSE | 80 crossover to downside | |
6.3. Candlestick Patterns
| Date | Candlestick Pattern |
|---|
6.4. Technical Score
Let's check the technical score of STRATA Skin Sciences Inc based on Penke's default Symbol scanner.
Penke's Symbol Scanner
| Indicator | Condition | Value | ||
|---|---|---|---|---|
| Rsi | Greater than | 50 | 51.062 | |
| Ma 20 | Greater than | Ma 50 | 0.503 | |
| Ma 50 | Greater than | Ma 100 | 0.501 | |
| Ma 100 | Greater than | Ma 200 | 0.525 | |
| Open | Greater than | Close | 0.529 | |
| Total | 3/5 (60.0%) | |||
Good job! You gained 25 XP and 0 0 10 . What's next:
- Share my analysis of STRATA Skin Sciences Inc with someone you think should read this too:
- Are you bullish or bearish on STRATA Skin Sciences Inc? Let me know what you think in the comments.
- Do you want an email if I find something interesting about STRATA Skin Sciences Inc? Add an email alert using the form below.
- Join the community if you want to keep your earnings and track your progress: Join the community
- Is this analysis useful to you? Support me via
. I'll analyze the stock market faster for you!
Get notifications about STRATA Skin Sciences Inc
I send you an email if I find something interesting about STRATA Skin Sciences Inc.